These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 11711256
1. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases. Treadway G, Reisman A. Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256 [Abstract] [Full Text] [Related]
2. Azithromycin. A review of its use in paediatric infectious diseases. Langtry HD, Balfour JA. Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451 [Abstract] [Full Text] [Related]
6. Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. Galova K, Sufliarska S, Kukova Z, Danisovicova A, Hrachova I, Grausova S, Marinova I, Krizan S, Stopkova K, Stahorska A, Durcanska K, Raskova J, Krupova I, Krcméry V. Chemotherapy; 1996 Aug; 42(3):231-4. PubMed ID: 8983893 [Abstract] [Full Text] [Related]
10. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group. Lauvau DV, Verbist L. J Int Med Res; 1997 Aug; 25(5):285-95. PubMed ID: 9364291 [Abstract] [Full Text] [Related]
12. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. Schaad UB, Kellerhals P, Altwegg M, Swiss Pharyngitis Study Group. Pediatr Infect Dis J; 2002 Apr; 21(4):304-8. PubMed ID: 12075761 [Abstract] [Full Text] [Related]
13. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. Tamm M, Todisco T, Feldman C, Garbino J, Blasi F, Hogan P, de Caprariis PJ, Hoepelman IM. Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728 [Abstract] [Full Text] [Related]
15. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. Gris P. J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850 [Abstract] [Full Text] [Related]